DOCEBO INC (DCBO) Fundamental Analysis & Valuation

NASDAQ:DCBO • CA25609L1058

Current stock price

17.47 USD
+0.79 (+4.74%)
At close:
17.13 USD
-0.34 (-1.95%)
After Hours:

This DCBO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. DCBO Profitability Analysis

1.1 Basic Checks

  • DCBO had positive earnings in the past year.
  • In the past year DCBO had a positive cash flow from operations.
  • Of the past 5 years DCBO 4 years were profitable.
  • Of the past 5 years DCBO 4 years had a positive operating cash flow.
DCBO Yearly Net Income VS EBIT VS OCF VS FCFDCBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

1.2 Ratios

  • The Return On Assets of DCBO (18.15%) is better than 94.55% of its industry peers.
  • DCBO has a better Return On Equity (50.63%) than 96.00% of its industry peers.
  • With an excellent Return On Invested Capital value of 28.07%, DCBO belongs to the best of the industry, outperforming 96.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for DCBO is significantly above the industry average of 10.92%.
  • The last Return On Invested Capital (28.07%) for DCBO is above the 3 year average (16.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.15%
ROE 50.63%
ROIC 28.07%
ROA(3y)11.32%
ROA(5y)6.27%
ROE(3y)34.17%
ROE(5y)19.81%
ROIC(3y)16.11%
ROIC(5y)N/A
DCBO Yearly ROA, ROE, ROICDCBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200

1.3 Margins

  • DCBO has a better Profit Margin (15.46%) than 81.82% of its industry peers.
  • DCBO's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 12.13%, DCBO is in the better half of the industry, outperforming 78.91% of the companies in the same industry.
  • DCBO has a Gross Margin of 80.42%. This is amongst the best in the industry. DCBO outperforms 82.18% of its industry peers.
  • DCBO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.13%
PM (TTM) 15.46%
GM 80.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y46.55%
PM growth 5YN/A
GM growth 3Y0%
GM growth 5Y-0.34%
DCBO Yearly Profit, Operating, Gross MarginsDCBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. DCBO Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DCBO is creating value.
  • Compared to 1 year ago, DCBO has less shares outstanding
  • The number of shares outstanding for DCBO has been reduced compared to 5 years ago.
  • DCBO has a worse debt/assets ratio than last year.
DCBO Yearly Shares OutstandingDCBO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DCBO Yearly Total Debt VS Total AssetsDCBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 2.73 indicates that DCBO is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of DCBO (2.73) is better than 64.00% of its industry peers.
  • The Debt to FCF ratio of DCBO is 0.09, which is an excellent value as it means it would take DCBO, only 0.09 years of fcf income to pay off all of its debts.
  • DCBO's Debt to FCF ratio of 0.09 is fine compared to the rest of the industry. DCBO outperforms 80.00% of its industry peers.
  • DCBO has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • DCBO's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. DCBO outperforms 60.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.09
Altman-Z 2.73
ROIC/WACC2.83
WACC9.93%
DCBO Yearly LT Debt VS Equity VS FCFDCBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • DCBO has a Current Ratio of 1.22. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
  • DCBO's Current ratio of 1.22 is on the low side compared to the rest of the industry. DCBO is outperformed by 64.73% of its industry peers.
  • A Quick Ratio of 1.22 indicates that DCBO should not have too much problems paying its short term obligations.
  • The Quick ratio of DCBO (1.22) is worse than 64.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
DCBO Yearly Current Assets VS Current LiabilitesDCBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. DCBO Growth Analysis

3.1 Past

  • DCBO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.98%, which is quite impressive.
  • The Earnings Per Share has been growing by 88.99% on average over the past years. This is a very strong growth
  • The Revenue has grown by 11.87% in the past year. This is quite good.
  • Measured over the past years, DCBO shows a very strong growth in Revenue. The Revenue has been growing by 30.99% on average per year.
EPS 1Y (TTM)56.98%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%18.42%
Revenue 1Y (TTM)11.87%
Revenue growth 3Y19.31%
Revenue growth 5Y30.99%
Sales Q2Q%10.51%

3.2 Future

  • Based on estimates for the next years, DCBO will show a very strong growth in Earnings Per Share. The EPS will grow by 22.29% on average per year.
  • The Revenue is expected to grow by 26.95% on average over the next years. This is a very strong growth
EPS Next Y18.91%
EPS Next 2Y18.91%
EPS Next 3Y20.92%
EPS Next 5Y22.29%
Revenue Next Year10.62%
Revenue Next 2Y11.22%
Revenue Next 3Y11.56%
Revenue Next 5Y26.95%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
DCBO Yearly Revenue VS EstimatesDCBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO Yearly EPS VS EstimatesDCBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

8

4. DCBO Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 12.94, DCBO is valued correctly.
  • Based on the Price/Earnings ratio, DCBO is valued cheaply inside the industry as 83.27% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of DCBO to the average of the S&P500 Index (25.35), we can say DCBO is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 10.88 indicates a reasonable valuation of DCBO.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of DCBO indicates a rather cheap valuation: DCBO is cheaper than 83.27% of the companies listed in the same industry.
  • DCBO is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.61, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.94
Fwd PE 10.88
DCBO Price Earnings VS Forward Price EarningsDCBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DCBO is valued cheaper than 82.55% of the companies in the same industry.
  • DCBO's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DCBO is cheaper than 75.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.48
EV/EBITDA 12.52
DCBO Per share dataDCBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • DCBO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • DCBO has an outstanding profitability rating, which may justify a higher PE ratio.
  • DCBO's earnings are expected to grow with 20.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y18.91%
EPS Next 3Y20.92%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DCBO Dividend Analysis

5.1 Amount

  • DCBO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DCBO Fundamentals: All Metrics, Ratios and Statistics

DOCEBO INC

NASDAQ:DCBO (3/31/2026, 4:30:01 PM)

After market: 17.13 -0.34 (-1.95%)

17.47

+0.79 (+4.74%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-27
Earnings (Next)05-07
Inst Owners32.89%
Inst Owner Change-4.8%
Ins Owners0.4%
Ins Owner ChangeN/A
Market Cap502.44M
Revenue(TTM)242.69M
Net Income(TTM)37.51M
Analysts80
Price Target25.57 (46.37%)
Short Float %6.42%
Short Ratio3.41
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.78%
Min EPS beat(2)1.01%
Max EPS beat(2)22.55%
EPS beat(4)4
Avg EPS beat(4)19.42%
Min EPS beat(4)1.01%
Max EPS beat(4)28.07%
EPS beat(8)7
Avg EPS beat(8)27.59%
EPS beat(12)10
Avg EPS beat(12)11.91%
EPS beat(16)13
Avg EPS beat(16)101.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)-0.86%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.54%
Revenue beat(12)2
Avg Revenue beat(12)-0.68%
Revenue beat(16)2
Avg Revenue beat(16)-0.99%
PT rev (1m)-0.7%
PT rev (3m)-7.01%
EPS NQ rev (1m)4.53%
EPS NQ rev (3m)2.08%
EPS NY rev (1m)5.32%
EPS NY rev (3m)5.32%
Revenue NQ rev (1m)0.98%
Revenue NQ rev (3m)3.06%
Revenue NY rev (1m)0.71%
Revenue NY rev (3m)3.1%
Valuation
Industry RankSector Rank
PE 12.94
Fwd PE 10.88
P/S 2.07
P/FCF 18.48
P/OCF 17.83
P/B 6.78
P/tB 8.59
EV/EBITDA 12.52
EPS(TTM)1.35
EY7.73%
EPS(NY)1.61
Fwd EY9.19%
FCF(TTM)0.95
FCFY5.41%
OCF(TTM)0.98
OCFY5.61%
SpS8.44
BVpS2.58
TBVpS2.03
PEG (NY)0.68
PEG (5Y)N/A
Graham Number8.85
Profitability
Industry RankSector Rank
ROA 18.15%
ROE 50.63%
ROCE 35.53%
ROIC 28.07%
ROICexc 263.9%
ROICexgc N/A
OM 12.13%
PM (TTM) 15.46%
GM 80.42%
FCFM 11.2%
ROA(3y)11.32%
ROA(5y)6.27%
ROE(3y)34.17%
ROE(5y)19.81%
ROIC(3y)16.11%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)20.39%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y46.55%
PM growth 5YN/A
GM growth 3Y0%
GM growth 5Y-0.34%
F-Score6
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.09
Debt/EBITDA 0.06
Cap/Depr 30.79%
Cap/Sales 0.4%
Interest Coverage 250
Cash Conversion 86.37%
Profit Quality 72.49%
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 2.73
F-Score6
WACC9.93%
ROIC/WACC2.83
Cap/Depr(3y)29.27%
Cap/Depr(5y)38.17%
Cap/Sales(3y)0.44%
Cap/Sales(5y)0.64%
Profit Quality(3y)239%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.98%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%18.42%
EPS Next Y18.91%
EPS Next 2Y18.91%
EPS Next 3Y20.92%
EPS Next 5Y22.29%
Revenue 1Y (TTM)11.87%
Revenue growth 3Y19.31%
Revenue growth 5Y30.99%
Sales Q2Q%10.51%
Revenue Next Year10.62%
Revenue Next 2Y11.22%
Revenue Next 3Y11.56%
Revenue Next 5Y26.95%
EBIT growth 1Y55.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year118.64%
EBIT Next 3Y44.38%
EBIT Next 5Y27.18%
FCF growth 1Y-2.9%
FCF growth 3Y182.43%
FCF growth 5Y48.94%
OCF growth 1Y-3.68%
OCF growth 3Y130.92%
OCF growth 5Y40.42%

DOCEBO INC / DCBO Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DOCEBO INC?

ChartMill assigns a fundamental rating of 7 / 10 to DCBO.


What is the valuation status for DCBO stock?

ChartMill assigns a valuation rating of 8 / 10 to DOCEBO INC (DCBO). This can be considered as Undervalued.


What is the profitability of DCBO stock?

DOCEBO INC (DCBO) has a profitability rating of 8 / 10.


What is the financial health of DOCEBO INC (DCBO) stock?

The financial health rating of DOCEBO INC (DCBO) is 6 / 10.


What is the earnings growth outlook for DOCEBO INC?

The Earnings per Share (EPS) of DOCEBO INC (DCBO) is expected to grow by 18.91% in the next year.